Share on StockTwits

Edap – Tms SA (NASDAQ:EDAP) announced its earnings results on Thursday. The company reported $0.05 EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.04) by $0.09, American Banking News reports. The company had revenue of $10.60 million for the quarter, compared to the consensus estimate of $9.30 million.

Edap – Tms SA (NASDAQ:EDAP) opened at 3.11 on Thursday. Edap – Tms SA has a 52-week low of $2.38 and a 52-week high of $4.48. The stock has a 50-day moving average of $3.08 and a 200-day moving average of $3.03. The company’s market cap is $67.8 million.

EDAP TMS SA (NASDAQ:EDAP) develops and markets the Ablatherm device, an advanced choice for high intensity focused ultrasound (HIFU) treatment of localized prostate cancer.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.